Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016927
Filing Date
2023-05-15
Accepted
2023-05-15 08:00:47
Documents
55
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 540953
2 ex31-1.htm EX-31.1 11847
3 ex31-2.htm EX-31.2 11821
4 ex31-3.htm EX-31.3 11820
5 ex32-1.htm EX-32.1 10402
  Complete submission text file 0001493152-23-016927.txt   3621883

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cocp-20230331.xsd EX-101.SCH 30505
7 XBRL CALCULATION FILE cocp-20230331_cal.xml EX-101.CAL 40368
8 XBRL DEFINITION FILE cocp-20230331_def.xml EX-101.DEF 127979
9 XBRL LABEL FILE cocp-20230331_lab.xml EX-101.LAB 278445
10 XBRL PRESENTATION FILE cocp-20230331_pre.xml EX-101.PRE 212140
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 461568
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 23918494
SIC: 2834 Pharmaceutical Preparations